title: Malaria and National Vector Borne Disease Control Programme.
abstract: Malaria is a major vector borne disease in India with significant morbidity and mortality. The official figure of 1.5 million cases annually is a gross under-estimation of the true incidence and the actual figures are estimated to be 10-100 times higher. The National Vector Borne Disease Control Programme (NVBDCP) directorate is the main body responsible for malaria control in India. Newer strategies including insecticide treated bednets, longlasting insecticidal bednets and rapid diagnostic tests have been used for malaria control in the last decade. Global assistance has come from the World Bank and Global fund in the form of Enhanced Malaria Control Programme(EMCP) and Intensified Malaria Control Programme(IMCP) respectively. Despite years of concerted global and national efforts, control of malaria continues to be a challenge. The emergence of drug resistance to anti-malarial drugs has been a major hurdle in its control. The NVBDCP has formulated new treatment guidelines for malaria in 2010 which recommend artemisinin based combination therapy (ACT) as the first-line drugs for P. falciparum malaria in the country. The article discusses the recent national drug policy for malaria and the rationale for its use.
authors: Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi 110001, India. drrajnisharma@yahoo.com
authors: Rajni
authors: R
authors: Sharma
authors: Ashok Kumar
authors: AK
authors: Dutta
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D007194:India; D007303:Insect Vectors; D008288:Malaria / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D009032:Mosquito Control; D009313:National Health Programs; D010961:Plasmodium / Q000187:drug effects
chemical_list: D000962:Antimalarials